Redburn upgrades Abbott Laboratories stock to Buy

Published on 10/06/2026 at 13:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Redburn raised its target to USD 127.00 on October 2, 2026. Abbott Laboratories stock costs EUR 89.19 on October 6, 2026 versus EUR 89.21.

Isometrisch 3D Diagnostik-Kette Abbott Laboratories US0028241000 — Abbott Laboratories US0028241000 isometrische 3D-Darstellung Diagnostik-Wertschöpfungskette Sample Analyse Report drei Stufen Teal, Illustration mit AI erstellt.

Abbott Laboratories (ISIN US0028241000) received a higher valuation from Rothschild & Co Redburn on October 2, 2026, when the research firm upgraded the stock from Neutral to Buy and raised its price target from USD 119.00 to USD 127.00, according to MarketBeat. The change puts Medical Devices at the center of the current valuation debate.

Redburn raises the target

The new USD 127.00 target compares with the previous USD 119.00 target, while MarketBeat cited an average analyst target of USD 119.80 and a Moderate Buy consensus. The upgrade gives investors a concrete benchmark ahead of Abbott's next results, rather than relying only on the recent share quotation.

The analyst action also rests on operating expectations. MarketBeat reported that Abbott delivered adjusted earnings per share of USD 1.31 in the second quarter of 2026 against USD 1.28 expected. Revenue reached USD 12.59 billion, up 13.00 percent from the same quarter a year earlier, and the company set adjusted full-year earnings-per-share guidance at USD 5.45-5.60.

Results set the next test

That combination matters because the next report will test whether the valuation lift is supported by fresh execution. Abbott is scheduled to publish third-quarter 2026 results before the market opens on October 21, 2026, according to TradingView.

The operating picture is diversified across medical devices, diagnostics, nutrition and established pharmaceuticals. That mix makes the upcoming report particularly relevant for the Medical Devices division, which was the business area cited in the October 2 analyst upgrade.

Abbott stock stays near EUR 89

Abbott Laboratories stock was trading at EUR 89.19 at Lang & Schwarz on October 6, 2026 at 1:00 p.m. CEST, with a minus 0.02 percent change versus the prior close of EUR 89.21. The reference price is in euros, while the Rothschild Redburn target and Abbott's reported figures are in US dollars.

The further course of trading is shown by the continuously updated real-time quote of Abbott Laboratories stock.